Redhawk Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,569
Closed -$828K 295
2024
Q3
$828K Buy
2,569
+96
+4% +$31.4K 0.12% 144
2024
Q2
$773K Sell
2,473
-175
-7% -$51.4K 0.12% 144
2024
Q1
$753K Buy
2,648
+131
+5% +$38.3K 0.12% 142
2023
Q4
$725K Sell
2,517
-638
-20% -$174K 0.14% 132
2023
Q3
$848K Sell
3,155
-44
-1% -$11K 0.28% 82
2023
Q2
$710K Sell
3,199
-776
-20% -$180K 0.22% 97
2023
Q1
$961K Buy
3,975
+57
+1% +$14K 0.32% 76
2022
Q4
$1.03M Buy
3,918
+298
+8% +$79.9K 0.4% 76
2022
Q3
$816K Buy
+3,620
New +$877K 0.35% 86

Other funds holding AMGN

Redhawk Wealth Advisors's AMGN Position: Q4 2024 in Review

Redhawk Wealth Advisors sold out of Amgen (AMGN) in Q4 2024, closing a stake of 2,569 shares — an estimated $828K sold.

Redhawk Wealth Advisors first reported a position in AMGN in Q3 2022 and held it in 9 quarters. The position peaked at $1.03M in Q4 2022. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Redhawk Wealth Advisors reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 2,569 Amgen shares in Q4 2024, an estimated $828K.
  • Redhawk Wealth Advisors first reported a position in Amgen in Q3 2022 and held it in 9 quarters.
  • Redhawk Wealth Advisors's Amgen position peaked at $1.03M in Q4 2022.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Redhawk Wealth Advisors's 13F filing for Q4 2024, filed 14 Jan 2025.